SCHEMBL23840307

SCHEMBL23840307

COc1ncc(NC(=O)c2cccc(N3CCCC3O)c2)cc1S(=O)(=O)Nc1ccc(Cl)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 4/20 0.44
FGFR1 P11362 4/20 0.44
KDR P35968 4/20 0.44
APOBEC3G Q9HC16 2/20 0.42
MAPT P10636 9/20 0.41
MEN1 O00255 6/20 0.41
KMT2A Q03164 6/20 0.41
HTT P42858 5/20 0.41
ALDH1A1 P00352 4/20 0.41
LMNA P02545 4/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
ALOX12 P18054 1/20 0.41
IDH1 O75874 2/20 0.41
GAA P10253 2/20 0.40
POLB P06746 2/20 0.40
KDM4E B2RXH2 2/20 0.40
CPT1A P50416 1/20 0.40
CPT1B Q92523 1/20 0.40
MAPK10 P53779 1/20 0.40
HPGD P15428 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25482879 0.84 NPC1 (0.52) EGFRFGFR1KDRMAPTMEN1
SCHEMBL23833491 0.81 EGFR (0.51) EGFRFGFR1KDRMAPTMEN1
SCHEMBL30151007 0.81 EGFR (0.51) EGFRFGFR1KDRMAPTMEN1
SCHEMBL23833425 0.80 MEN1 (0.41) EGFRFGFR1KDRAPOBEC3GMAPT
SCHEMBL23840607 0.76 NPC1 (0.44) MEN1KMT2AHTTALDH1A1SMN1; SMN2
SCHEMBL23833405 0.76 MAPT (0.53) APOBEC3GMAPTMEN1KMT2AHTT
SCHEMBL23833480 0.75 GPR27 (0.48) MAPTMEN1KMT2AHTTALDH1A1
SCHEMBL30151063 0.75 GPR27 (0.48) MAPTMEN1KMT2AHTTALDH1A1
SCHEMBL23833438 0.75 DRD2 (0.47) EGFRFGFR1KDRAPOBEC3GMAPT
SCHEMBL30151019 0.75 DRD2 (0.47) EGFRFGFR1KDRAPOBEC3GMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021188907-A1 PYRIDINESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF AMATHUS THERAPEUTICS, INC. (US) 2021-09-23 WO disclosed